Moving Beyond Somatic Alterations: Uncovering the Germline Basis of Myeloid Malignancies.
1/5 보강
Myeloid neoplasms (MNs) with germline predisposition represent a distinct, increasingly recognized category in the WHO classification, encompassing myelodysplastic syndrome (MDS) and acute myeloid leu
APA
Elbaz Younes I, Nguyen L, Zhang L (2026). Moving Beyond Somatic Alterations: Uncovering the Germline Basis of Myeloid Malignancies.. Cancers, 18(2). https://doi.org/10.3390/cancers18020240
MLA
Elbaz Younes I, et al.. "Moving Beyond Somatic Alterations: Uncovering the Germline Basis of Myeloid Malignancies.." Cancers, vol. 18, no. 2, 2026.
PMID
41595160 ↗
Abstract 한글 요약
Myeloid neoplasms (MNs) with germline predisposition represent a distinct, increasingly recognized category in the WHO classification, encompassing myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) arising in the context of an inherited genetic alteration or mutation. While often presenting at a younger age or with characteristic cytopenias with or without organ dysfunction, some can manifest in adulthood, highlighting the need for vigilance regardless of age or family history. Key predisposing genes include transcription factors (e.g., , ) and genes involved in RNA splicing and telomere biology disorders. Identification of these germline mutations is critical as MNs with germline predisposition dictate specific therapeutic strategies-particularly for hematopoietic stem cell transplantation (HSCT)-and require genetic counseling and surveillance for at-risk relatives. Accurate diagnosis often requires non-hematopoietic germline DNA testing, which provides important biological insights into the development of different myeloid neoplasms and directs personalized patient care.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Synergistic adverse prognosis of and co-mutation in acute myeloid leukemia: a retrospective cohort study.
- A Review of CEBPA's Role in Hereditary Leukemia.
- Lifetime risk of solid tumors and leukemia in Down Syndrome: a population-based Swedish matched cohort study.
- Spontaneous remission of congenital acute megakaryoblastic leukemia in a neonate with down syndrome.
- A novel positive-feedback loop between CEBPA and NAT10 promotes non-small cell lung cancer progression.
- Single cell transcriptional evolution of myeloid leukemia of Down syndrome.